加强新型冠状病毒肺炎患者肝损伤的临床研究

doi:10.3969/j.issn.1672-5069.2020.02.001

Abstract

Sun Chao, Fan Jiangao. Strengthen clinical research on liver injury in patients with novel corona virus pneumonia[J]. Journal of Practical Hepatology, 2020, 23(2): 153-155.

[1] 新型冠状病毒感染的肺炎诊疗方案(试行第五版). 2020, http://www.gov.cn/zhengce/zhengceku/2020-02/05/content_5474791.htm
[2] Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020 Jan 31. doi: 10.1056/NEJMoa2001191.
[3] Chen NS, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020 Jan 30. pii: S0140-6736(20)30211-7. doi: 10.1016/S0140-6736(20)30211-7.
[4] Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol, 2020 Jan 22. doi: 10.1002/jmv.25681.
[5] Chau TN, Lee KC, Yao H, et al. SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases. Hepatology, 2004, 39(2): 302-310.
[6] Lee JY, Kim YJ, Chung EH, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis, 2017,17(1): 498.
[7] Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet 2020 Jan 24. pii: S0140-6736(20)30154-9. doi: 10.1016/S0140-6736(20)30154-9.
[8] Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of 2019 novel coronavirus infection in China. 2020 doi: http://dx.doi.org/10.1101/2020.02.06.20020974.
[9] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Jan 24. pii: S0140-6736(20)30183-5. doi: 10.1016/S0140-6736(20)30183-5.
[10] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 Feb 7. doi: 10.1001/jama.2020.1585.
[11] Chai XQ, Hu LF, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. 2020, doi:http://dx.doi.org/10.1101/2020.02.03.931766.
[12] 杨永峰. 不明原因肝病诊断思路. 实用肝脏病杂志, 2018,21(1):1-3.

[1]	Wang Hongxue, Zhu Qingjing, Zhang Yujuan , et al. Efficacy of cetylcysteine combined with magnesium isoglycyrrhizinate in treatment of patients with drug-induced liver injuries [J]. Journal of Practical Hepatology, 2020, 23(2): 227-230.
[2]	Wang Jianhui, Guo Hongdan, Kong Jingjing, et al. Clinical characteristics and risk factors ofdrug-induced liver injury caused by antituberculosis therapy [J]. Journal of Practical Hepatology, 2020, 23(1): 58-61.
[3]	Gao Lei, Cao Lei, Wang Ruifang, et al.. Protective effect of human umbilical cord mesenchymal stem cell transplantation on alcoholic liver injury in rats [J]. Journal of Practical Hepatology, 2019, 22(6): 812-815.
[4]	Hu Qunfeng, Yang Li. Pregnancy outcomes in 112 patients with liver injuries during gestation periods [J]. Journal of Practical Hepatology, 2019, 22(5): 664-667.
[5]	Wu Xin, Guo Yangzhi, Du Xiaorang, et al. Clinical features of herb-induced liver injury [J]. Journal of Practical Hepatology, 2019, 22(5): 668-671.
[6]	Du Min, Zhou Min, Ji Zongshu. Clinical features and risk factors of liver injuries in patients with sepsis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 369-372.
[7]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[8]	Liu Liwei, Zhao Xinyan. Clinicopathological features of drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 160-163.
[9]	Huang Chunyang, Shan Jing, Liao Huiyu, Huang Yunli, Han Ying, Zhang Xiaodan, Du Xiaofei, Ren Meixin, Bian Xinqu, Liu Yanmin. Clinical and laboratory characteristics of patients with drug-induced liver injury receiving glucocorticoid therapy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 208-211.
[10]	Wu Xiuxin, Zhang Huiyong, Zhang Kai. Changes of plasma microRNA-4284 in patients with anti-tuberculosis drug-induced hepatotoxicity [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 212-215.
[11]	Song Fangjiao, Zhu Bing, Lyu Sa, Tian Hua, Wang Haibo, Xin Shaojie, You Shaoli. Clinical analysis of drug-induced liver failure：a report of 314 cases [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 216-219.
[12]	Guo Lele, Zhang Xiaohui, Zhang Xiangying, et al.. Expression of glycosyltransferase Colgalt2 in liver tissues of mice with acetaminophen-induced acute liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 29-32.
[13]	Sun Wenjing, Chen Dongfeng.. Literature analysis about RUCAM scale and Maria scale in diagnosis of Chinese patients with drug-induced liver injury [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 881-884.
[14]	Sui Ling, Du Jikun, Zheng Jingbin.. Protective effect of curcumin on CCl₄-induced acute liver injury in rats [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 709-712.
[15]	Wang Nian, Wei Chunling, Jiang Shishuang, et al. Protective effect of neferine on mice with D-GalN / LPS-induced acute liver injury by inhibiting oxidative stress [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(4): 545-548.

Strengthen clinical research on liver injury in patients with novel corona virus pneumonia

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments